Product Information

XTAMPZA ER 27 MG CAPSULE is a brand product labeled by Collegium Pharmaceutical, Inc., priced at $15.8622 per EA under NDC 24510013010. Its NADAC has been published 407 times since Mar 22, 2017.

XTAMPZA ER 27 MG CAPSULE

OXYCODONE
$15.8622per EA
DEA Schedule CII

Strength

27 mg/1

NDC

24510013010

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

12/18/2024

Active Ingredients

OXYCODONE

Approval Type

New Drug (NDA)

FDA Application

NDA208090

On Market Since

5/10/2016

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for XTAMPZA ER 27 MG CAPSULE has been published 407 times since Mar 22, 2017, and over the history we have for it it has risen 74.1%. The table below summarizes its recorded NADAC range and movement.

Current price$15.8622 per EA
All-time high$15.8701 (Aug 14, 2024)
All-time low$8.7693 (May 17, 2017)
Median price$13.3879
Average price$12.8384
Largest weekly change+9.9% (Jan 1, 2020)
Weeks tracked407
Tracking sinceMar 22, 2017

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+2.6%

5Y

+18.5%

All

+74.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the OXYCODONE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of XTAMPZA ER 27 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for XTAMPZA ER 27 MG CAPSULE, manufactured by Collegium Pharmaceutical, Inc., is $15.8622 per EA (NDC 24510013010), effective Jan 1, 2025.

How has the price of XTAMPZA ER 27 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for XTAMPZA ER 27 MG CAPSULE has risen 74.1%. It has been tracked across 407 weekly CMS publications since Mar 22, 2017.

What are the highest and lowest recorded NADAC prices for XTAMPZA ER 27 MG CAPSULE?

Since Mar 22, 2017, the NADAC for XTAMPZA ER 27 MG CAPSULE has ranged from a low of $8.7693 (May 17, 2017) to a high of $15.8701 (Aug 14, 2024), with a median of $13.3879 per EA.

Are there cheaper alternatives to XTAMPZA ER 27 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of XTAMPZA ER 27 MG CAPSULE, so no direct lower-cost alternative is listed.

Who manufactures XTAMPZA ER 27 MG CAPSULE?

XTAMPZA ER 27 MG CAPSULE (NDC 24510013010) is labeled by Collegium Pharmaceutical, Inc., and CMS classifies it as a brand product.